Home/Industries/Pharma & Life Sciences
Regulated content, without the wait.
MLR review queues, manual tagging, and unaccountable media spend stall pharma content programs. NextRow ships governed AI with an audit trail.
PROOF · PHARMA OUTCOMES
Numbers from inside regulated content operations.
Documented and anonymized. Full write-ups on Results.
70%
MLR review cost and time saved with QuipMLR
up to 80%
faster metadata tagging with QuipTag for AEM at a Fortune 100 pharma
$4M
recoverable media spend identified per year by KoruIQ at a Fortune 100 pharma
24×5
managed operations from NextRow's global delivery centers
WHAT WE SHIP HERE
Four systems pharma teams put into production.
QUIPMLR FOR MLR REVIEW
Pre-screens content against claims libraries and prior rulings, cutting MLR review cost and time by 70%. Platform-agnostic, human sign-off.
QUIPTAG: METADATA AT FORTUNE 100 SCALE
AI metadata authoring for AEM Assets: up to 80% faster tagging across thousands of assets at a Fortune 100 pharmaceutical company, into Adobe Analytics and CJA.
KORUIQ PROTECTS MEDIA SPEND
Observability across data integrity, tags, and media delivery. KoruIQ identified $4M per year in recoverable media spend at a Fortune 100 pharma.
AI GOVERNANCE FOR REGULATED WORKFLOWS
Approval gates, non-destructive scopes, credential isolation, and allowlists let legal, IT, and compliance say yes to AI.
PLATFORM DEPTH
Built on the stack pharma already runs.
Adobe CX Enterprise
Adobe Gold Solution Partner depth across AEM, Marketo, Workfront, and the content supply chain.
ADOBE PRACTICE →Salesforce
Marketo-to-Salesforce marketing operations: lead lifecycle, sync health, and attribution for field and HCP marketing teams.
SALESFORCE PRACTICE →Anthropic Claude
Governed Claude agents and copilots. The same AI layer powers QuipMLR and QuipTag.
AI SERVICES →START HERE
The FrontRow entry point for pharma teams.
01 Assess → 02 Pilot → 03 Production → 04 Run, starting with a Claude Readiness Assessment.
CLAUDE READINESS ASSESSMENT (FROM $15,000)
A 4 to 6 week, fixed-scope engagement: executive alignment, prioritized AI use cases with ROI, a governance model MLR and IT can review, and a 90-day plan.
WHY FIXED SCOPE MATTERS IN PHARMA
The FrontRow methodology keeps every stage fixed-fee and gated, so procurement, legal, and compliance approve a bounded step.
PROOF
Built in regulated environments.
SAVED
70%
Of Medical-Legal-Regulatory review cost and time with QuipMLR
Every gate still carries human sign-off. QuipTag delivers up to 80% faster metadata tagging on the same estate.
ANSWERS · FAQ
What pharma content and compliance leaders ask
QuipMLR applies agentic AI to Medical-Legal-Regulatory review and cuts review cost and time by 70%. It pre-screens promotional and medical content against claims libraries, reference packages, and prior rulings before human reviewers see it, so committees spend their time on judgment calls rather than mechanical checks. QuipMLR is platform-agnostic and was built by NextRow, an Anthropic Claude Certified Partner.
Yes. QuipTag for AEM delivered up to 80% faster metadata tagging at a Fortune 100 pharmaceutical company, across thousands of assets. It authors metadata inside Adobe Experience Manager Assets and connects to Adobe Analytics and Customer Journey Analytics, so tagging quality shows up downstream in search, reuse, and reporting.
Every NextRow agent runs inside an explicit governance model: approval gates before consequential actions, non-destructive operating scopes, credential isolation, and system allowlists. That model is documented for legal and IT review as part of every engagement, and NextRow, as an Anthropic Claude Certified Partner, aligns deployments with Anthropic usage policies.
KoruIQ is NextRow's MarTech observability platform. It monitors data integrity, tags, and media delivery across your marketing stack. At a Fortune 100 pharmaceutical company, KoruIQ identified $4M per year in recoverable media spend by catching broken tracking and misfiring tags before budgets were wasted.
Engagements start with the FrontRow assessment stage. For pharma teams that usually means a Claude Readiness Assessment, a fixed-scope engagement from $15,000 that runs 4 to 6 weeks. It ends with prioritized use cases with ROI, a governance model your compliance team can review, and a 90-day plan.
No. NextRow publishes pharma results anonymized by policy, such as up to 80% faster tagging and $4M per year in recoverable media spend at a Fortune 100 pharmaceutical company. The numbers are documented from real engagements; the names stay confidential.
Take the queue out of regulated content.
A fixed-scope Life Sciences AI assessment ends in prioritized use cases with ROI, a governance model, and a 90-day plan.